P. J. Perry

1.2k total citations
20 papers, 872 citations indexed

About

P. J. Perry is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, P. J. Perry has authored 20 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in P. J. Perry's work include Bipolar Disorder and Treatment (8 papers), Treatment of Major Depression (5 papers) and Electroconvulsive Therapy Studies (4 papers). P. J. Perry is often cited by papers focused on Bipolar Disorder and Treatment (8 papers), Treatment of Major Depression (5 papers) and Electroconvulsive Therapy Studies (4 papers). P. J. Perry collaborates with scholars based in United States. P. J. Perry's co-authors include Del D. Miller, Remi J. Cadoret, Stephan Arndt, William R. Yates, James D Hoehns, Fergal J. Fleming, Timothy L. Holman, Brian C. Lund, Ming T. Tsuang and Laurence M. Demers and has published in prestigious journals such as American Journal of Psychiatry, Journal of Affective Disorders and Psychiatry Research.

In The Last Decade

P. J. Perry

20 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. J. Perry United States 12 526 216 138 120 101 20 872
William E. Falk United States 15 473 0.9× 243 1.1× 120 0.9× 99 0.8× 85 0.8× 31 940
M. Andrew Berisford United States 9 852 1.6× 212 1.0× 97 0.7× 169 1.4× 109 1.1× 11 1.2k
Thomas J. Arndt United States 8 760 1.4× 171 0.8× 105 0.8× 71 0.6× 131 1.3× 8 1.1k
Jack Hirschowitz United States 22 812 1.5× 164 0.8× 272 2.0× 41 0.3× 136 1.3× 63 1.4k
T. Kolakowska United Kingdom 18 905 1.7× 115 0.5× 172 1.2× 110 0.9× 78 0.8× 30 1.2k
John Cookson United Kingdom 19 772 1.5× 138 0.6× 106 0.8× 102 0.8× 74 0.7× 62 1.1k
André Tapp United States 13 532 1.0× 134 0.6× 55 0.4× 140 1.2× 44 0.4× 29 887
Stephen Kaplita United States 9 609 1.2× 268 1.2× 88 0.6× 51 0.4× 58 0.6× 18 961
Dan Zimbroff United States 12 890 1.7× 266 1.2× 198 1.4× 64 0.5× 116 1.1× 21 1.3k
Robert A. Leadbetter United States 15 984 1.9× 378 1.8× 116 0.8× 228 1.9× 90 0.9× 22 1.5k

Countries citing papers authored by P. J. Perry

Since Specialization
Citations

This map shows the geographic impact of P. J. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. J. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. J. Perry more than expected).

Fields of papers citing papers by P. J. Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. J. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. J. Perry. The network helps show where P. J. Perry may publish in the future.

Co-authorship network of co-authors of P. J. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of P. J. Perry. A scholar is included among the top collaborators of P. J. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. J. Perry. P. J. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carnahan, Ryan M., et al.. (2025). The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents. Psychopharmacology Bulletin. 36(4). 14–18. 2 indexed citations
2.
Doroudgar, Shadi, et al.. (2015). An 11-year retrospective review of venlafaxine ingestion in children from the California Poison Control System. Human & Experimental Toxicology. 35(7). 767–774. 6 indexed citations
3.
Carnahan, Ryan M., Brian C. Lund, P. J. Perry, & Elizabeth A. Chrischilles. (2005). Increased risk of extrapyramidal side‐effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatrica Scandinavica. 113(2). 135–141. 43 indexed citations
4.
Perry, P. J., et al.. (2003). Measures of Aggression and Mood Changes in Male Weightlifters With and Without Androgenic Anabolic Steroid Use. Journal of Forensic Sciences. 48(3). 1–6. 80 indexed citations
6.
Miller, Del D., Fergal J. Fleming, Timothy L. Holman, & P. J. Perry. (1994). Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.. PubMed. 55 Suppl B. 117–21. 96 indexed citations
7.
Hoehns, James D & P. J. Perry. (1993). Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.. PubMed. 12(11). 814–28. 53 indexed citations
8.
Miller, Del D., P. J. Perry, Remi J. Cadoret, & Nancy C. Andreasen. (1993). Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Schizophrenia Research. 9(2-3). 245–245. 1 indexed citations
9.
Perry, P. J., Del D. Miller, Stephan Arndt, & Remi J. Cadoret. (1991). Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients [published erratum appears in Am J Psychiatry 1991 Oct;148(10):1427]. American Journal of Psychiatry. 148(2). 231–235. 259 indexed citations
10.
Noyes, R & P. J. Perry. (1990). Maintenance treatment with antidepressants in panic disorder.. PubMed. 51 Suppl A. 24–30. 20 indexed citations
11.
Yates, William R., et al.. (1990). Illicit anabolic steroid use: a controlled personality study. Acta Psychiatrica Scandinavica. 81(6). 548–550. 48 indexed citations
12.
Garvey, M J, et al.. (1989). Is DST status associated with depression characteristics?. Journal of Affective Disorders. 16(2-3). 159–165. 2 indexed citations
13.
Holstad, Sheldon G., et al.. (1988). The effects of intravenous theophylline infusion versus intravenous Sodium Bicarbonate infusion on Lithium clearance in normal subjects. Psychiatry Research. 25(2). 203–211. 11 indexed citations
14.
Perry, P. J., Jessica L. Browne, Randall A. Prince, Bruce Alexander, & Ming T. Tsuang. (1986). Effects of Smoking on Nortriptyline Plasma Concentrations in Depressed Patients. Therapeutic Drug Monitoring. 8(3). 279–284. 22 indexed citations
15.
Perry, P. J., et al.. (1985). Relationship of free nortriptyline levels to therapeutic response. Acta Psychiatrica Scandinavica. 72(2). 120–125. 8 indexed citations
16.
Perry, P. J., et al.. (1985). Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients. Journal of Affective Disorders. 8(1). 47–53. 28 indexed citations
17.
Schneider, Philip J., et al.. (1984). Liquid Chromatographic Determination of Methyldopa and Methyldopa-Thiazide Combinations in Tablets: Collaborative Study. Journal of AOAC INTERNATIONAL. 67(6). 1118–1120. 2 indexed citations
18.
Perry, P. J., et al.. (1984). Theophylline precipitated alterations of lithium clearance. Acta Psychiatrica Scandinavica. 69(6). 528–537. 17 indexed citations
19.
Perry, P. J., et al.. (1981). Lithium kinetics in single daily dosing. Acta Psychiatrica Scandinavica. 64(4). 281–294. 39 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026